ArticleNAR molecular medicine2026
Identification of enzymatically modified isoquercitrin as a therapeutic lead for myotonic dystrophy type 1.
Subodh K Mishra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it